glutathione epigenetic drug resistance

glutathione epigenetic drug resistance deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies Epigenetic plasticity in cancer drug

Name: glutathione epigenetic drug resistance deregulation in breast cancer microenvironment: Implications for tumor progression and therapeutic strategies Epigenetic plasticity in cancer drug
Brand: creatorsinfotech.com
SKU: 50925940397
Price: 22.84 USD
Availability: InStock
Rating: 4.4527 (30 reviews)

Epigenetic plasticity in cancer drug resistance: mechanistic insights and strategies for therapeutic intervention Acta Pharmacologica Sinica Epigenetic modifications: Key players in cancer heterogeneity and drug resistance PMC Glutathione S transferase Theta 2 causes drug resistance by inhibiting arsenic trioxide induced ferroptosis in pancreatic ductal adenocarcinoma ScienceDirect Epigenetic modifications in cancer drug resistance: molecular mechanisms and therapeutic interventions Molecular Biomedicine Springer Nature Link Targeting epigenetic regulators to overcome drug resistance in cancers Signal Transduction and Targeted Therapy

SKU: 50925940397 · From creatorsinfotech.com

4.5

USD22.84 USD48.84

Pay in 4 interest-free payments of $5.71 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Oct 27 - Nov 1

Description

For example: GLP-1 peptides for metabolic health collagen peptides for skin health However, its important to distinguish regulated peptide therapy from unregulated peptide research chemicals , which may not meet pharmaceutical standards